Max Healthcare to introduce 24×7 ward monitoring system

New Delhi, To bring Intensive Care Unit (ICU)-standard monitoring across general wards, Max Healthcare on Wednesday announced a partnership with US-based medical technology company Vios Medical to launch a continuous vital monitoring system built on a medical-grade Internet of Things (IoT) framework.

The technology provides continuous monitoring of vital signs such as oxygen saturation, heart rate, respiratory rate, electrocardiogram (ECG) and blood pressure in general wards, thereby enabling early detection and critical care facility even outside an ICU set-up.

The VIOS ward monitoring system comprises two connected sensors — chest and finger — which communicate wirelessly (via Bluetooth) with a bed-side tablet that maps all vital trends.

These, along with alarms (in case of adverse episodes/ change in trends), can be remotely viewed by nursing staff and clinicians at nursing stations and smartphones via web links.

This ensures that hospital staff can continuously monitor even the patients who are in rooms and ensure better care, Max Healthcare said in a statement.

“The psychosis/anxiety felt by patients under long term critical care has a strong impact on their recovery. With this technology solution, patients can experience 24×7 critical monitoring, even outside an ICU environment, helping them recover in the comfortable presence of loved ones,” said Sandeep Budhiraja, Clinical Director at Max Healthcare.

The technology also aids clinicians in making more effective treatment plans by providing vital trends and patterns, the statement added.

A successful pilot of the system, covering several specialties such as Cardiology, Pulmonology, Medicine and Neurology was conducted at Max Healthcare, Dehradun.

The system, which has the potential to reduce up to 30 per cent critical care costs as compared to ICU charges, will be launched soon across all network hospitals under Max Healthcare, the statement added.

  • Related Posts

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharmaceutical Industries Ltd has announced that it has entered into a definitive agreement under which it will acquire all outstanding shares of Organon for $14.00 per share in an…

    HP accounts for 47 inferior drugs in March alert

    Kullu: In an alert issued for the month of March, the Central Drugs Standard Control Organisation (CDSCO) has declared a total of 141 drugs to be of substandard quality. Out…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert

    Civil society group SAM calls for greater transparency involving clinical trials

    Civil society group SAM calls for greater transparency involving clinical trials

    Different packaging, typos expose fake Mounjaro racket

    Different packaging, typos expose fake Mounjaro racket

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore